Fetal brain vulnerability to SARS-CoV-2 infection
Brain, Behavior, and Immunity · 2023
DOI: 10.1016/j.bbi.2023.06.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2023. Verfasst von Courtney L McMahon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Developmental and Regenerative Biology, University of Texas at San Antonio, San Antonio, TX 78249, USA; Brain Health Cons…. Hauptthemen laut MEDLINE: COVID-19, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Whether or not SARS-CoV-2 can cross from mother to fetus during a prenatal infection has been controversial; however, recent evidence such as viral RNA detection in umbilical cord blood and amniotic fluid, as well as the discovery of additional entry receptors in fetal tissues suggests a potential for viral transmission to and infection of the fetus. Furthermore, neonates exposed to maternal COVID-19 during later development have displayed neurodevelopmental and motor skill deficiencies, suggesting the potential for consequential neurological infection or inflammation in utero. Thus, we investigated transmission potential of SARS-CoV-2 and the consequences of infection on the developing brain using human ACE2 knock-in mice. In this model, we found that viral transmission to the fetal tissues, including the brain, occurred at later developmental stages, and that infection primarily targeted male fetuses. In the brain, SARS-CoV-2 infection largely occurred within the vasculature, but also within other cells such as neurons, glia, and choroid plexus cells; however, viral replication and increased cell death were not observed in fetal tissues. Interestingly, early gross developmental differences were observed between infected and mock-infected offspring, and high levels of gliosis were seen in the infected brains 7 days post initial infection despite viral clearance at this time point. In the pregnant mice, we also observed more severe COVID-19 infections, with greater weight loss and viral dissemination to the brain, compared to non-pregnant mice. Surprisingly, we did not observe an increase in maternal inflammation or the antiviral IFN response in these infected mice, despite showing clinical signs of disease. Overall, these findings have concerning implications regarding neurodevelopment and pregnancy complications of the mother following prenatal COVID-19 exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroscience, Developmental and Regenerative Biology, University of Texas at San Antonio, San Antonio, TX 78249, USA; Brain Health Consortium, University of Texas at San Antonio, San Antonio, TX 78249, USA.
- Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
- NIDA NIH HHS
Zitieren
APA
McMahon, C. L., Castro, J., Silvas, J., Muniz Perez, A., Estrada, M., Carrion, R., & Hsieh, J. (2023). Fetal brain vulnerability to SARS-CoV-2 infection. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2023.06.015
Vancouver
McMahon CL, Castro J, Silvas J, Muniz Perez A, Estrada M, Carrion R, et al. Fetal brain vulnerability to SARS-CoV-2 infection. Brain, Behavior, and Immunity. 2023. doi:10.1016/j.bbi.2023.06.015
BibTeX
@article{McMahon2023,
author = {McMahon, Courtney L and Castro, Joshua and Silvas, Jesus and Muniz Perez, Aranis and Estrada, Manuel and Carrion, Ricardo and Hsieh, Jenny},
title = {Fetal brain vulnerability to SARS-CoV-2 infection},
journal = {Brain, Behavior, and Immunity},
year = {2023},
doi = {10.1016/j.bbi.2023.06.015}
}
EUVIMED